Sofosbuvir plus velpatasvir treatment for hepatitis C virus in patients with decompensated cirrhosis: a Japanese real-world multicenter study

JSH Guidelines for the Management of Hepatitis C Virus Infection, 2019 Update; Protective Effect of Antiviral Therapy against Hepatocarcinogenesis

(2020) Yasuhiro Asahina et al.   HEPATOLOGY RESEARCH

Glecaprevir and Pibrentasvir for Japanese patients with chronic hepatitis C genotype 1 or 2 infection: Results from a multicenter, real-world cohort study

(2019) Eiichi Ogawa et al.   HEPATOLOGY RESEARCH

Real‐world efficacy of elbasvir and grazoprevir for hepatitis C virus (genotype 1): A nationwide, multicenter study by the Japanese Red Cross Hospital Liver Study Group

(2019) Toshie Mashiba et al.   HEPATOLOGY RESEARCH

Intention‐to‐treat Assessment of Glecaprevir + Pibrentasvir Combination Therapy for Patients with Chronic Hepatitis C in the Real World

(2019) Akihiro Tamori et al.   HEPATOLOGY RESEARCH

Involvement of portosystemic shunts in impaired improvement of liver function after direct‐acting antiviral therapies in cirrhotic patients with hepatitis C virus

(2019) Shohei Tsuji et al.   HEPATOLOGY RESEARCH

Real-world virological efficacy and safety of elbasvir and grazoprevir in patients with chronic hepatitis C virus genotype 1 infection in Japan

(2018) Hidenori Toyoda et al.   JOURNAL OF GASTROENTEROLOGY

Real-world efficacy and safety of ledipasvir and sofosbuvir in patients with hepatitis C virus genotype 1 infection: a nationwide multicenter study by the Japanese Red Cross Liver Study Group

(2018) Keiji Tsuji et al.   JOURNAL OF GASTROENTEROLOGY

EASL Recommendations on Treatment of Hepatitis C 2018

(2018) Jean-Michel Pawlotsky et al.   JOURNAL OF HEPATOLOGY

Efficacy and safety of sofosbuvir–velpatasvir with or without ribavirin in HCV-infected Japanese patients with decompensated cirrhosis: an open-label phase 3 trial

(2018) Tetsuo Takehara et al.   JOURNAL OF GASTROENTEROLOGY

Treatment with direct-acting antivirals improves the clinical outcome in patients with HCV-related decompensated cirrhosis: results from an Italian real-life cohort (Liver Network Activity—LINA cohort)

(2018) Ivan Gentile et al.   Hepatology International

The presence of varices in patients after hepatitis C eradication predicts deterioration in the FIB‐4 index

(2018) Yuya Seko et al.   HEPATOLOGY RESEARCH

Treatment of hepatitis C virus infection in patients with cirrhosis and predictive value of model for end-stage liver disease: Analysis of data from the Hepa-C registry

(2017) Carlos Fernández Carrillo et al.   HEPATOLOGY

Delisting of liver transplant candidates with chronic hepatitis C after viral eradication: A European study

(2016) Luca Saverio Belli et al.   JOURNAL OF HEPATOLOGY

Impact of direct acting antiviral therapy in patients with chronic hepatitis C and decompensated cirrhosis

(2016) Graham R. Foster et al.   JOURNAL OF HEPATOLOGY

Outcomes after successful direct-acting antiviral therapy for patients with chronic hepatitis C and decompensated cirrhosis

(2016) Michelle C.M. Cheung et al.   JOURNAL OF HEPATOLOGY

Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis

(2015) Michael P. Curry et al.   NEW ENGLAND JOURNAL OF MEDICINE